No Placebo Group
Every participant receives an active treatment — no one gets a placebo.
Healthy Volunteers Welcome
You do not need to have the condition being studied to take part.
Ready to participate?
Review the details below, then apply to join this clinical trial.
At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
46 (estimated)
Sponsor
School of Health Sciences Geneva · Other
Who this trial is looking for
Think this trial could be right for you?
Answer a few quick questions to see if you may meet the eligibility requirements.
Stroke is one of the leading causes of long-term disability worldwide. Many individuals who survive a stroke continue to experience weakness and reduced control of one arm, even months or years after the event. These motor impairments significantly affect independence, daily activities, and quality of life. Despite rehabilitation efforts, recovery of upper limb function remains incomplete for many…
Stroke is one of the leading causes of long-term disability worldwide. Many individuals who survive a stroke continue to experience weakness and reduced control of one arm, even months or years after the event. These motor impairments significantly affect independence, daily activities, and quality of life. Despite rehabilitation efforts, recovery of upper limb function remains incomplete for many patients.
Motor recovery after stroke depends on the brain's ability to reorganize itself, a process known as neuroplasticity. Recent research suggests that motor learning and brain recovery are influenced not only by activity in the primary motor cortex (M1), but also by its functional connectivity with other brain regions, particularly the parietal cortex (PC). Strengthening communication between these regions may enhance motor recovery.
This study aims to investigate a novel, non-invasive brain stimulation approach called intermittent theta-burst stimulation (iTBS). Unlike traditional stimulation methods that target a single brain region, this study uses a multifocal stimulation protocol targeting both the primary motor cortex and the parietal cortex. The stimulation is combined with structured motor training using an interactive tablet-based rehabilitation device (REAtouch®Lite 2), designed to improve arm movement through goal-directed reaching tasks.
The study is a single-center, randomized, sham-controlled, triple-blind clinical trial with parallel groups. Thirty-six individuals with chronic stroke-related upper limb impairment will be randomly assigned to receive either active multifocal iTBS or sham (placebo) stimulation. Both groups will complete identical motor training sessions. In addition, ten healthy participants will complete the same motor training protocol (without brain stimulation) to provide reference data.
Participants will attend six visits over approximately 10 days. Assessments will include motor performance tests using the interactive tablet, a standardized clinical motor scale (Fugl-Meyer Assessment for Upper Extremity), and resting-state electroencephalography (EEG) to measure brain connectivity changes.
The primary outcome is improvement in motor performance between baseline and one week after the intervention. Secondary outcomes include short-term motor improvements, retention of learning, changes in movement quality, and changes in brain functional connectivity.
This study seeks to determine whether combining multifocal brain stimulation with targeted motor training can enhance motor learning and promote better recovery of arm function after stroke. If effective, this approach could contribute to the development of more precise, network-based neurorehabilitation strategies.
Trial Locations
Loading…
Loading trial locations…
Facility
City
State
Country
Status
Eligibility Criteria
Inclusion Criteria:
For Stroke Participants:
* Age ≥ 18 years
* First-ever ischemic or hemorrhagic stroke
* Time since stroke ≥ 6 months
* Unilateral upper limb hemiparesis
* Fugl-Meyer Assessment Upper Extremity (FMA-UE) score between 29 and 57
* Modified Ashworth Scale score \< 2 at elbow, wrist…
Inclusion Criteria:
For Stroke Participants:
* Age ≥ 18 years
* First-ever ischemic or hemorrhagic stroke
* Time since stroke ≥ 6 months
* Unilateral upper limb hemiparesis
* Fugl-Meyer Assessment Upper Extremity (FMA-UE) score between 29 and 57
* Modified Ashworth Scale score \< 2 at elbow, wrist, or finger flexors
* Manual muscle testing ≥ 3/5 in proximal upper limb muscles (deltoid, biceps, triceps, wrist pronators/supinators)
* Ability to understand and follow study procedures
* Provided written informed consent
For Healthy Participants:
* Age ≥ 18 years
* No history of neurological disease
* Ability to understand and follow study procedures
* Provided written informed consent
Exclusion Criteria:
For Stroke Participants:
* Second stroke occurring during the study period
* Botulinum toxin injection within 3 months prior to study start
* History of one or more epileptic seizures
* Metallic object near the stimulation site
* Implanted electronic or metallic devices (e.g., pacemaker, neurostimulator) incompatible with TMS
* Severe comorbid conditions affecting the upper limb (traumatic, rheumatologic, osteoarticular, or neurodegenerative disorders)
* Pregnancy
* Delirium or impaired vigilance
* Inability to participate in one-hour treatment sessions
* Inability to comply with study procedures (e.g., language barrier, psychological disorder, dementia)
* Current or past substance abuse, including excessive alcohol consumption
* Participation in another interventional clinical trial within 30 days prior to enrollment
For Healthy Participants:
* Severe musculoskeletal or neurological condition affecting the non-dominant upper limb
* Pregnancy
* Delirium or impaired vigilance
* Inability to participate in one-hour treatment sessions
* Inability to comply with study procedures
* Current or past substance abuse, including excessive alcohol consumption
* Participation in another interventional clinical trial within 30 days prior to enrollment
Picking one helps us show the most relevant trials first.
Your results are loading in the background — you can
change this any time from the results page.
Set your location to continue
Find My Trials uses your location to surface clinical trials near you.
Add your city or zip code to your profile and try again.